Combined pulmonary fibrosis and emphysema -case report and literature review;Wspótistnienie wtóknienia i rozedmy płue -opis przypadku i przegla̧d literatury

Pneumonologia i Alergologia Polska

Volumn 77, Issue 2, 2009, Pages 205-210

  Kosacka, Monika ^a   Brzecka, Anna ^a   Jankowska, Renata ^a   Lewczuk, Jerzy ^b   Mroczek, Ewa ^b   Weryñska, Bozena ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Oerodek Badawczo Rozwojowy Wojewodzkiego Szpitala Specjallstycznego we Wrocawiu Ordynator ^*  (Poland)

Author keywords

Chronic respiratory failure; Combined pulmonary fibrosis and emphysema; Pulmonary hypertension

Indexed keywords

ELECTROCARDIOGRAPHY; HUMAN; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG FUNCTION TEST; MALE; MIDDLE AGED; PULMONARY HYPERTENSION; RADIOGRAPHY; REVIEW; SYNDROME; TOBACCO;

ELECTROCARDIOGRAPHY; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; SYNDROME; TOBACCO;

EID: 69849101395     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wiggins J., Strickland E., Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assesment. Respir. Med. 1990; 84: 365-369.
2. Lim T.K. Respiratory failure from, combined emphysema and pulmonary fibrosis. Singapore Med. J. 1993; 34: 169-171.
3. Grabstein A., Bendayan D., Schactman I., Cohen M., Shitrit D., Kramer M.R. Concomitant upper lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir. Med. 2005; 99: 948-954.
4. Jankowich M..II, Polsky M., Klein M., Rounds S. Heterogenity in combined pulmonary fibrosis and emphysema. Respiration 2008; 75: 411-417.
5. Cottin V., Nunes H., Drillet P.-Y. i wsp. Combined pulmonary fibrosis and emphysema: a distinct, underrecognised entity. Eur. Respir. J. 2005; 26: 588-593.
6. Cottin V., Brillet P.Y., Nunes H. i wsp. Combined pulmonary fibrosis and emphysema. Presse Med. 2007; 36: 938-944.
7. Rogliani P., Mura M., Mattia P. i wsp. HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema Respir. Med. 2008; 22 [epub ahead of print].
8. Wesolowski S., Oniszh. K., Kuš J. Znaczenie kliniczne typu zmian w obrazie tomografii komputerowej wysokiej rozdzielczości u chorych na samoistne włókníenie płuc. Pneumonol. Alergol. Pol. 2000; 68: 434-440.
9. Bestry I., Oniszh K., Pawlicka L., Dobkowski P. Rola metod obrazowych w diagnostyce środmia̧źszowych chorob płuc. W: E. Rowińska-Zakrzewska, E. Wiatr, M. Pirożyński (red.). Choroby śródmia̧ższowe płuc, α-medica press 2001; 24-67.
10. Lewczuk J. Nadciśnienie płucne w śró dmia̧ższowych chorobah płuc. Pneumonol. Alergol. Pol. 2007; 75: 153-157.
11. Lettieri C.J., Nathan S.D., Barnett. S.D., Ahmad S., Shorr A.F. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746-752.
12. Nathan S.D., Shlobin O.A., Ahmad S., Urbanek S., Barnett S.D. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007; 131: 657-663.
13. Hamada K., Nagai S., Tanaka S. i wsp. Significance of pulmonary arterial pressure and diffusion capacity of the lungs as prognosticate! in patients with idiopathic pulmonary fibrosis. Chest 2007; 131: 650-656.
14. Schachna L., Wigley F.M., Chang B., White B., Wise R.A., Gelber A.C. Age and risk of pulmonary arterial hypertension in scleroderma. Chest 2003; 124: 2098-2104.
15. Weizenblum E., Chaouat A., Kessler R., Canuet M. Overlap syndrome: obstructive sleep apnea syndrome in patients with chronic obstructive pulmonary disease. Proc, Am. Thorac Soc. 2008; 15: 237-241.
16. Brzecka A. Przyczyny wtórnej erytrocytozy u chorych z zespolem obturacyjnego bezdechu środsennego. Adv. Clin. Exp. Med. 2001; 10: 133-138.
17. Daniil Z., Koutsokera A., Gourgouliainis K. Combined pulmonary fibrosis and emhysema in patients exposed to agrochemical compounds. Eur. Respir. J, 2006; 27: 434.
18. Lundblad L.K., Thompson-Figueroa J., Leclair T. i wsp. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am. J. Respir. Crit. Care Med. 2005; 171: 1363-1370.